ask="0.3750"
ask_size="1500"
average_daily_volume="2014480"
bid="0.3300"
bid_size="4900"
book_value="0.1680"
change="-0.0015"
change_from_200_day_moving_average="0.0118"
change_from_50_day_moving_average="0.0477"
change_from_52_week_high="-0.7635"
change_From_52_week_low="0.0765"
change_in_percent="-0.4190%"
close="0.3565"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3800"
high_52_weeks="1.1200"
last_trade_date="2/10/2017"
last_trade_price="0.3565"
last_trade_size="4900"
last_trade_time="4:00pm"
low="0.3450"
low_52_weeks="0.2800"
market_capitalization="91.67M"
moving_average_200_day="0.3447"
moving_average_50_day="0.3088"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+3.4305%"
percent_change_from_50_day_moving_average="+15.4514%"
percent_change_from_52_week_high="-68.1696%"
percent_change_from_52_week_low="+27.3214%"
previous_close="0.3580"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.1310"
price_per_sales="1.6900"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.3300"
stock_exchange="NCM"
symbol="PPHM"
volume="3758304"
weeks_range_52="0.2800 - 1.1200"
